This site is intended for health professionals only

Covid-19 Primary Care Resources


Covid vaccinations in children



Evidence and guidance for Covid vaccinations in children

This information is sourced from the RCPCH, The Green Book and the BMJ:

Evidence on Vaccinations in Children

  • SARS-CoV-2 vaccine trials have only just begun in children and there are very limited data on safety and immunogenicity in this group
  • Trials are currently under way to test the Pfizer and Moderna vaccines in children
  • Currently the Oxford-AstraZeneca vaccine trial in children has been paused
  • There are some safety data on the Pfizer vaccine in children aged 12 years and older

Children who are currently eligible for vaccination

  • Covid-19 vaccines are not routinely recommended for children and young people under 16 years of age
  • The only other group identified by the Joint Committee on Vaccination and Immunisation (JCVI) that should be considered for the vaccine during phase 1 are older children (aged 12 years and over) with severe neuro-disabilities and recurrent respiratory tract infections who require residential care
  • Such vaccinations would be considered unlicensed use and paediatricians should discuss the benefits and risks and limited safety data with children, young people and their parents/guardians

Young people